1-14 of 14
William Slayton
Close
Sort by
Journal Articles

Real-World Implementation of Sickle Cell Transition Programs As Part of a State Quality Improvement Network

Ofelia A. Alvarez, Carrie Gann, Debbie Ringdahl, Manisha Bansal, Farranaz Alvarez-Nunez, William Slayton, Reema Kashif, Tung Wynn, Elizabeth Bradley, Kathryn Diener, Katrina Rivers, Sherry Buchman, Angela Chatfield, Monica Heldreth, Virginia Crowe, Sue Butts-Dion
Journal: Blood
Blood (2023) 142 (Supplement 1): 249.
https://doi.org/10.1182/blood-2023-173886
Published: 2023
Journal Articles

Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy Among Acute Lymphoblastic Leukemia Patients

Mansi Dalal, MD, William Slayton, MD, Phuong Tan Tran, BS Pharm, MPH, Joshua David Brown, PharmD, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-142563
Published: 2020
Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Stephen P. Hunger, MD, Vaskar Saha, MD PhD, Meenakshi Devidas, Maria Grazia Valsecchi, Julie Gastier Foster, Gianni Cazzaniga, PhD, Shalini C. Reshmi, PhD, Michael Borowitz, MD PhD, Anthony Moorman, Nyla A. Heerema, PhD, Andrew J. Carroll, III, PhD, Phillip Barnette, M. Monica Monica Gramatges, MD, Kelly Maloney, MD, Weili Sun, MD PhD, Rene Swanink, Amanda Termuhlen, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Lewis B. Silverman, MD, Martin Schrappe, MD PhD, Kirk R. Schultz, William Slayton, MD, Diane Healey, Andrea Biondi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 98.
https://doi.org/10.1182/blood.V130.Suppl_1.98.98
Published: 2017
Journal Articles

Digital Drug Screening and Computational Modeling Identifies Treatment Opportunities Despite Lack of Directly Actionable Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Leylah M. Drusbosky, PhD, Kimberly E. Hawkins, PhD BS, Madeleine Turcotte, MS, Hemant S. Murthy, MD, Helen L. Leather, Nosha Farhadfar, MD, Maxim Norkin, MD, John R. Wingard, MD, John W. Hiemenz, MD, Paul Castillo, MD, Randy A. Brown, MD, William Slayton, MD, Biljana N. Horn, MD, Sumanth Vasista, BE, Kabya Basu, MS, Shahabuddin Usmani, MS, Kunal Ghosh Roy, MS, Deepak Anil Lala, BT, Saumya Radhakrishnan, BT, Rajeev Kumar, BT, Swaminathan Rajagopalan, MT, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Christopher R. Cogle, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3910.
https://doi.org/10.1182/blood.V130.Suppl_1.3910.3910
Published: 2017
Journal Articles

Icare 1: A Prospective Clinical Trial to Predict Treatment Response Based on Mutanome-Informed Computational Biology in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Leylah M. Drusbosky, PhD, Kimberly E. Hawkins, PhD BS, Cesia Salan, Madeleine Turcotte, MS, Glenda G. Anderson, Neeraj Kumar Singh, B.Tech, Saumya Radhakrishnan, BT, Yashaswini Ullal, BE, Anay Talawdekar, MT, Huzaifa Sikora, BT, Prashant Nair, BT, Priyanka Bhowmick, MS, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Fei Zou, PhD, Nosha Farhadfar, MD, Hemant S. Murthy, MD, Biljana N. Horn, MD, Helen L. Leather, Paul Castillo, MD, Barry Sawicki, BS, Randy A. Brown, MD, Maxim Norkin, MD, John W. Hiemenz, MD, Jack W. Hsu, MD, William Slayton, MD, John R. Wingard, MD, Christopher R. Cogle, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4277.
https://doi.org/10.1182/blood.V130.Suppl_1.4277.4277
Published: 2017
Journal Articles

High Concentration of CXCR4 Antagonist AMD3100 Is Able to Surrender t(4;11) Leukemia Cells

Zhongbo Hu, MD, PhD, Matthew Perez, Xiaomiao Li, PhD, William Slayton, MD
Journal: Blood
Blood (2011) 118 (21): 4257.
https://doi.org/10.1182/blood.V118.21.4257.4257
Published: 2011
Journal Articles

Neonatal Megakaryocytes Do Not Mature Normally In the Absence of Thrombopoietin In Vivo: Potential Role of Developmental Differences In CXCR4 Expression

Francisca Ferrer-Marin, MD, PhD, Ravi K. Gutti, Ph.D., Zhi-Jian Liu, Ph.D., Joseph Italiano, Ph.D., Zhongbo Hu, MD, PhD, William Slayton, MD, Martha Sola-Visner, MD
Journal: Blood
Blood (2010) 116 (21): 88.
https://doi.org/10.1182/blood.V116.21.88.88
Published: 2010
Journal Articles

Screening Small Molecule Inhibitors of VLA-5 to Block the Interaction Between Acute Lymphoblastic Leukemia with Ph+ and Their Microenvironment.

Zhongbo Hu, MD, PhD, Xiaomiao Li, PhD, David Ostrov, PhD, William Slayton, MD
Journal: Blood
Blood (2010) 116 (21): 1027.
https://doi.org/10.1182/blood.V116.21.1027.1027
Published: 2010
Journal Articles

High Levels of Acetylated Low Density Lipoprotein Uptake and Low Tie2 Promoter Activity Distinguishes Sinusoids from Other Vessel Types in the Murine Bone Marrow

Xiaomiao Li, Ph.D., Zhongbo Hu, MD, PhD, Marda Jorgenson, William Slayton, MD
Journal: Blood
Blood (2008) 112 (11): 5465.
https://doi.org/10.1182/blood.V112.11.5465.5465
Published: 2008
Journal Articles

Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, William Paul Bowman, William Slayton, MD, Alexander Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD, PhD, Stella M. Davies, MBBS, PhD, Michael Trigg, MD, Bernice Pasut, RN, Dean Jorstad, RPh, Tammie Eslinger, CCRP, Laura Burden, CCRP, Chenguang Wang, MS, Robert Rutledge, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 911.
https://doi.org/10.1182/blood.V112.11.911.911
Published: 2008
Journal Articles

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, W. Paul Bowman, MD, William Slayton, MD/PhD, Alex Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD/PhD, Stella M. Davies, MD/PhD, Michael Trigg, MD, Bernice Pasut, Dean Jorstad, Tammie Eslinger, Laura E. Burden, Chenguang Wang, PhD, Robert Rutledge, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen Hunger, MD/PhD, William L. Carroll, MD/PhD, Bruce Camitta, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 4.
https://doi.org/10.1182/blood.V110.11.4.4
Published: 2007
Journal Articles

MafG-Null Mice Show Delayed Leukocyte Engraftment Following Whole Bone Marrow Transplant.

Abu-Bakr Zafar, Xiao-Miao Li, PhD, Marda L. Jorgensen, Zhongbo Hu, PhD, Jorg Bungert, PhD, James Engel, PhD, William Slayton, MD
Journal: Blood
Blood (2006) 108 (11): 1322.
https://doi.org/10.1182/blood.V108.11.1322.1322
Published: 2006
Journal Articles

Minimal Toxicity of Imatinib Mesylate in Combination with Intensive Chemotherapy for Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL0031 Protocol for Very High Risk ALL.

Kirk R. Schultz, MD, Alexander Aledo, MD, W. Paul Bowman, MD, William Slayton, MD, PhD, Harland Sather, PhD, Cheryl L. Willman, PhD, Julie M. Gastier-Foster, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Michael J. Borowitz, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, PhD, William L. Carroll, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 283.
https://doi.org/10.1182/blood.V108.11.283.283
Published: 2006
Journal Articles

Newborn Mice Do Not Increase Their Megakaryocyte Mass in Response to Immune Thrombocytopenia.

Zhongbo Hu, PhD, William Slayton, MD, Lisa M. Rimsza, MD, Martha Sola-Visner, MD
Journal: Blood
Blood (2005) 106 (11): 2171.
https://doi.org/10.1182/blood.V106.11.2171.2171
Published: 2005